Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Panel of Microbiome Markers for Predicting CHF Outcomes

NCT06573892 is registered in ClinicalTrials.gov with Nazarbayev University as lead sponsor.

NCT NCT06573892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06573892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Panel of Microbiome Markers for Predicting CHF Outcomes
Lead sponsor
Nazarbayev University
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2024
Completion date
October 31, 2025
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure